20
Participants
Start Date
October 31, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate
0.1% NVC-422 in saline, up to 100 mL, Study Part 1 - once on Day 1 held in the bladder for 1 hour; Study Part 2 (Part 2a - 0.1% NVC-422, Part 2b - 0.2% NVC-422), once daily for 7 days, held in the bladder for 1 hour
Michael E. Debakey V.A. Medical Center, Houston
Lead Sponsor
NovaBay Pharmaceuticals, Inc.
INDUSTRY